MALVERN, Pa. & MONTREAL, QC—-Gemin X announced today that results of several clinical and preclinical studies of its lead anti-cancer candidate obatoclax will be presented at the 49th annual meeting of the American Society of Hematology in Atlanta, GA.
Read More at Business Wire via Yahoo! Finance…
No related posts.